Development of Protective Immunity in New Zealand White Rabbits Challenged with Bacillus anthracis Spores and Treated with Antibiotics and Obiltoxaximab, a Monoclonal Antibody agai...

por Henning, Lisa N., Carpenter, Sarah, Stark, Gregory V., Serbina, Natalya V.
Publicado 2018

Induction of M3-Restricted Cytotoxic T Lymphocyte Responses by N-Formylated Peptides Derived from Mycobacterium tuberculosis

por Chun, Taehoon, Serbina, Natalya V., Nolt, Dawn, Wang, Bin, Chiu, Nancy M., Flynn, JoAnne L., Wang, Chyung-Ru
Publicado 2001

Obiltoxaximab Prevents Disseminated Bacillus anthracis Infection and Improves Survival during Pre- and Postexposure Prophylaxis in Animal Models of Inhalational Anthrax

por Yamamoto, Brent J., Shadiack, Annette M., Carpenter, Sarah, Sanford, Daniel, Henning, Lisa N., Gonzales, Nestor, O'Connor, Edward, Casey, Leslie S., Serbina, Natalya V.
Publicado 2016

Efficacy Projection of Obiltoxaximab for Treatment of Inhalational Anthrax across a Range of Disease Severity

por Yamamoto, Brent J., Shadiack, Annette M., Carpenter, Sarah, Sanford, Daniel, Henning, Lisa N., O'Connor, Edward, Gonzales, Nestor, Mondick, John, French, Jonathan, Stark, Gregory V., Fisher, Alan C., Casey, Leslie S., Serbina, Natalya V.
Publicado 2016